Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Chinese Patent Office
Boehringer Ingelheim
Deloitte
Cerilliant
AstraZeneca
Colorcon
McKesson
US Army

Generated: June 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,629,327

« Back to Dashboard

Summary for Patent: 5,629,327
Title: Methods and compositions for inhibition of angiogenesis
Abstract:The present invention comprises a group of compounds that effectively inhibit angiogenesis. More specifically, thalidomide and various related compounds such as thalidomide precursors, analogs, metabolites and hydrolysis products have been shown to inhibit angiogenesis. Importantly, these compounds can be administered orally.
Inventor(s): D'Amato; Robert (Lancaster, PA)
Assignee: Childrens Hospital Medical Center Corp. (Boston, MA)
Application Number:08/168,817
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 5,629,327
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 5,629,327

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 5,629,327

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 218865 ➤ Try a Free Trial
Austria 304356 ➤ Try a Free Trial
Australia 6248694 ➤ Try a Free Trial
Australia 676722 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Fish and Richardson
Daiichi Sankyo
Baxter
Healthtrust
Cantor Fitzgerald
US Army
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.